The Coalition for Epidemic Preparedness Innovations (CEPI) is on a mission to explore whether new vaccines could be developed against emerging infectious diseases within just 100 days. With their recent successes and a range of advantages over traditional vaccine platforms, emerging rapid response technologies, like mRNA, are expected to play a significant role in achieving this goal.
From telehealth to decentralised trials, the entire healthcare industry has realised the true value of digitalisation in recent years. Medical affairs teams are no exception. Here, we discuss the benefits and challenges of engaging medical professionals on digital channels.
No clinical study can take place without informed consent. But with studies becoming increasingly complex and often remote, it’s the right time to take that step forward to reimagine how the consent process is managed.